CAMBRIDGE, Mass., Oct. 9 /PRNewswire-FirstCall/ -- Vertex
Pharmaceuticals Incorporated (Nasdaq GS: VRTX) will announce its third
quarter 2006 financial results on Thursday, October 26, 2006 after the
financial markets close. The Company will host a conference call at 5:00
p.m. Eastern Time. The conference call also will be webcast.
The live webcast will be available to all interested parties through
Vertex's website, http://www.vrtx.com, and will be archived on the
Company's website until November 9, 2006. To access the webcast, go to the
investor section and select 'Events & Presentations.' To ensure a timely
connection, it is recommended that users register at least 15 minutes prior
to the scheduled webcast.
About Vertex
Vertex Pharmaceuticals Incorporated is a global biotechnology company
committed to the discovery and development of breakthrough small molecule
drugs for serious diseases. The Company's strategy is to commercialize its
products both independently and in collaboration with major pharmaceutical
companies. Vertex's product pipeline is focused on viral diseases,
inflammation, autoimmune diseases, cancer, pain and bacterial infection.
Vertex co-discovered the HIV protease inhibitor, Lexiva, with
GlaxoSmithKline.
Lexiva is a registered trademark of the GlaxoSmithKline group of
companies.
Vertex's press releases are available at http://www.vrtx.com.
Vertex Contact:
Lora Pike, Manager, Investor Relations, (617)-444-6755
SOURCE Vertex Pharmaceuticals Incorporated
 back to top
Related links:
http://www.vrtx.com/
http://www.prnewswire.com/comp/938395.html /
CONTACT:
Lora Pike, Manager, Investor Relations of
Vertex Pharmaceuticals, +1-617-444-6755
|
